Rasna Therapeutics (RASP) 10-K/A 2017 FY Annual report (amended)

Exhibit 31.4

CERTIFICATION BY CHIEF ACCOUNTING OFFICER PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,AS ADOPTED SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Tiziano Lazzaretti, certify that:

1. I have reviewed this Amendment No. 1 to Form 10-K/A of Rasna Therapeutics, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Dated: June 30, 2017

/s/ Tiziano Lazzaretti

Name: Tiziano Lazzaretti

Title: Chief Financial Officer

          (Principal Financial Officer)